{"id":257494,"date":"2026-09-18T15:39:25","date_gmt":"2026-09-18T10:09:25","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=257494"},"modified":"2026-09-18T15:39:25","modified_gmt":"2026-09-18T10:09:25","slug":"why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-18","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-18\/","title":{"rendered":"Glaxosmithkline Pharmaceuticals Ltd. (GLAXO): Glaxosmithkline Pharmaceuticals Share Price rises 3.20% today to Rs 2,890"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/glaxo\/glaxosmithkline-pharmaceuticals-ltd-share-price-today\">Glaxosmithkline Pharmaceuticals Ltd. (GLAXO)<\/a> share price rose to Rs 2,890 today, up 3.2% from the previous close. Market cap was Rs 48,345.94 crore.<\/em><\/div>\n<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong> 18 September 2026 at 3:33:23 PM IST<\/p>\n<p style=\"margin-top:0!important;\">Glaxosmithkline Pharmaceuticals Share Price rose today as GLAXO moved to Rs 2,890, up 3.20% from the previous close of Rs 2,800.45. The company\u2019s market capitalisation now stands at Rs 48,345.94 crore, placing the move in a large-value market context without any company-specific catalyst confirmed by the supplied data.<\/p>\n<p>The stock opened at Rs 2,800.45, touched a day low of Rs 2,800.45 and a day high of Rs 2,890, and closed at the day\u2019s high. Turnover stood at Rs 1.85 crore. For readers tracking Glaxosmithkline Pharmaceuticals Share Price Today, the verified data confirms a same-day rise, but it does not establish why the move happened. This GLAXO Stock News update therefore focuses on the price event, valuation backdrop, sector comparison and the key facts investors can monitor on Univest.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-18\/#Glaxosmithkline_Pharmaceuticals_Share_Price_Today_Price_Action_Analysis\" title=\"Glaxosmithkline Pharmaceuticals Share Price Today: Price Action Analysis\">Glaxosmithkline Pharmaceuticals Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-18\/#Glaxosmithkline_Pharmaceuticals_Ltd_GLAXO_Fundamental_Analysis\" title=\"Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) Fundamental Analysis\">Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-18\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-18\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-18\/#Why_Investors_Are_Watching_Glaxosmithkline_Pharmaceuticals\" title=\"Why Investors Are Watching Glaxosmithkline Pharmaceuticals\">Why Investors Are Watching Glaxosmithkline Pharmaceuticals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-18\/#About_Glaxosmithkline_Pharmaceuticals\" title=\"About Glaxosmithkline Pharmaceuticals\">About Glaxosmithkline Pharmaceuticals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-18\/#Track_Glaxosmithkline_Pharmaceuticals_Share_Price_on_Univest\" title=\"Track Glaxosmithkline Pharmaceuticals Share Price on Univest\">Track Glaxosmithkline Pharmaceuticals Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-18\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-18\/#Why_did_Glaxosmithkline_Pharmaceuticals_Share_Price_rise_today\" title=\"Why did Glaxosmithkline Pharmaceuticals Share Price rise today?\">Why did Glaxosmithkline Pharmaceuticals Share Price rise today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-18\/#What_is_Glaxosmithkline_Pharmaceuticals_Share_Price_today\" title=\"What is Glaxosmithkline Pharmaceuticals Share Price today?\">What is Glaxosmithkline Pharmaceuticals Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-18\/#What_is_the_market_capitalisation_of_Glaxosmithkline_Pharmaceuticals\" title=\"What is the market capitalisation of Glaxosmithkline Pharmaceuticals?\">What is the market capitalisation of Glaxosmithkline Pharmaceuticals?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-18\/#How_is_Glaxosmithkline_Pharmaceuticals_valued_versus_peers\" title=\"How is Glaxosmithkline Pharmaceuticals valued versus peers?\">How is Glaxosmithkline Pharmaceuticals valued versus peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-18\/#What_do_ROE_and_ROCE_show_for_Glaxosmithkline_Pharmaceuticals_Share_Price\" title=\"What do ROE and ROCE show for Glaxosmithkline Pharmaceuticals Share Price?\">What do ROE and ROCE show for Glaxosmithkline Pharmaceuticals Share Price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-price-rise-2026-09-18\/#Where_can_I_track_Glaxosmithkline_Pharmaceuticals_Share_Price_on_Univest\" title=\"Where can I track Glaxosmithkline Pharmaceuticals Share Price on Univest?\">Where can I track Glaxosmithkline Pharmaceuticals Share Price on Univest?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Glaxosmithkline_Pharmaceuticals_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Glaxosmithkline Pharmaceuticals Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,890<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,800.45<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 89.55 (+3.2%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,800.45<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,890<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,800.45<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1.85 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 48,345.94 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Large Cap<\/td>\n<\/tr>\n<\/table>\n<p>Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) rose to Rs 2,890 from the previous close of Rs 2,800.45, a move of Rs 89.55 or 3.2%. The stock opened at Rs 2,800.45, reached a high of Rs 2,890, recorded a low of Rs 2,800.45.<\/p>\n<p>Glaxosmithkline Pharmaceuticals Share Price Today reflects a straight upward move from Rs 2,800.45 to Rs 2,890, a gain of Rs 89.55 or 3.20%. The stock traded between the same day\u2019s low of Rs 2,800.45 and high of Rs 2,890, which means the session finished at the high point of the day. Turnover of Rs 1.85 crore provides a factual traded-value reference for the session. In simple terms, the data confirms a clear share price rise, but it does not establish a company-specific trigger. For GLAXO Stock News readers, the most relevant takeaway is that today\u2019s move was cleanly positive and fully defined by the supplied price data.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Glaxosmithkline_Pharmaceuticals_Ltd_GLAXO_Fundamental_Analysis\"><\/span><strong>Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 48,345.94 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">44.41x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.82x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.76%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">66.79%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 63.05<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 148.77<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.04%<\/td>\n<\/tr>\n<\/table>\n<p>Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) fundamental metrics show P\/E 44.41x, P\/B 18.82x, ROE 48.76%, ROCE 66.79%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Glaxosmithkline Pharmaceuticals Ltd. has a market capitalisation of Rs 48345.94 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 44.41x, P\/B at 18.82x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 48.76% and ROCE of 66.79%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 63.05, book value per share of Rs 148.77, dividend yield of 2.04%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P\/E of 32.69x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">44.41x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.69x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">44.72x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.44x to 417.17x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.82x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.1x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.76%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.78%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">66.79%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.65%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 48,345.94 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 741.38 crore<\/td>\n<\/tr>\n<\/table>\n<p>Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a P\/E ratio of 44.41x, which is above the benchmark median of 32.69x, a difference of +35.85%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a ROE of 48.76%, which is above the benchmark median of 11.78%, a difference of +313.92%. Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a ROCE of 66.79%, which is above the benchmark median of 13.65%, a difference of +389.3%.<\/p>\n<p>Track stocks leading today through the <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,44,716.74<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">37.01<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.18<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi-s-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Divi&#39;s Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,44,223.13<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">84.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.05<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,83,453.32<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">85.3<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.73<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,10,224.17<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.14<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,09,848.55<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">32.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.15<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a P\/E ratio of 44.41x compared with the displayed peer median of 37.01x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 48.76% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 66.79% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a market capitalisation of Rs 48,345.94 crore. Among the 5 peers shown, 5 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Glaxosmithkline_Pharmaceuticals\"><\/span><strong>Why Investors Are Watching Glaxosmithkline Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Glaxosmithkline Pharmaceuticals Share Price rose 3.20% today to Rs 2,890, and the session ended at the day\u2019s high.<\/li>\n<li>The company\u2019s market capitalisation is Rs 48,345.94 crore, which gives the move a large-capitalisation context in the Healthcare sector.<\/li>\n<li>P\/E stands at 44.41 and P\/B at 18.82, so GLAXO Share Price is trading on elevated valuation multiples.<\/li>\n<li>ROE of 48.76% and ROCE of 66.79% are both well above the same-industry benchmark medians.<\/li>\n<li>Turnover of Rs 1.85 crore and dividend yield of 2.04% add extra context to Glaxosmithkline Pharmaceuticals Share Price Today.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Glaxosmithkline_Pharmaceuticals\"><\/span><strong>About Glaxosmithkline Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Glaxosmithkline Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. The company\u2019s supplied business context is centred on its listed pharmaceutical identity rather than on a broader segment breakdown, so Glaxosmithkline Pharmaceuticals Share Price is best understood through its market position, profitability ratios and valuation metrics. The stock is listed on NSE and BSE under the symbol GLAXO, and its market capitalisation places it well above the median company size in the same industry dataset. For readers comparing GLAXO Stock News with broader sector coverage, the important point is that the company combines high ROE, high ROCE, EPS of Rs 63.05 and book value of Rs 148.77 with a premium P\/B ratio. That mix makes it a closely followed name in Healthcare-oriented stock news and stock analysis coverage on Univest.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Glaxosmithkline_Pharmaceuticals_Share_Price_on_Univest\"><\/span><strong>Track Glaxosmithkline Pharmaceuticals Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/glaxo\/glaxosmithkline-pharmaceuticals-ltd-share-price-today\">Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top-gainers lists and related market analysis.<\/p>\n<p>Investors can track Glaxosmithkline Pharmaceuticals Share Price on Univest for live share price updates, company news, fundamental ratios, shareholding pattern, 52-week levels and market insights. The platform also helps users follow GLAXO Share Price Today alongside broader stock performance, peer comparison and sector context in one place. For those scanning Glaxosmithkline Pharmaceuticals Latest News or Glaxosmithkline Pharmaceuticals Share News, Univest keeps the data organised and easy to review without replacing factual market updates with commentary.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Glaxosmithkline_Pharmaceuticals_Share_Price_rise_today\"><\/span><strong>Why did Glaxosmithkline Pharmaceuticals Share Price rise today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied data confirms a 3.20% rise to Rs 2,890, but it does not establish a company-specific catalyst. The session closed at the day\u2019s high, which is the clearest verified price fact available.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Glaxosmithkline_Pharmaceuticals_Share_Price_today\"><\/span><strong>What is Glaxosmithkline Pharmaceuticals Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Glaxosmithkline Pharmaceuticals Share Price today is Rs 2,890. It rose Rs 89.55 from the previous close of Rs 2,800.45, giving the stock a 3.20% same-day gain in verified market data.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Glaxosmithkline_Pharmaceuticals\"><\/span><strong>What is the market capitalisation of Glaxosmithkline Pharmaceuticals?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The company\u2019s market capitalisation is Rs 48,345.94 crore. That places Glaxosmithkline Pharmaceuticals Share Price in a sizeable category within the Pharmaceuticals &amp; Drugs industry, based on the supplied benchmark set.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_is_Glaxosmithkline_Pharmaceuticals_valued_versus_peers\"><\/span><strong>How is Glaxosmithkline Pharmaceuticals valued versus peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> GLAXO trades at a P\/E of 44.41 and P\/B of 18.82. Its P\/E is below Divi\u2019s and Torrent but above Sun Pharma, Cipla and Zydus, while its P\/B is the highest in the supplied peer group.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_ROE_and_ROCE_show_for_Glaxosmithkline_Pharmaceuticals_Share_Price\"><\/span><strong>What do ROE and ROCE show for Glaxosmithkline Pharmaceuticals Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> ROE is 48.76% and ROCE is 66.79%. Both are above the same-industry benchmark medians, which is useful context when reviewing Glaxosmithkline Pharmaceuticals Share Price alongside its premium valuation ratios. The previous close was Rs 2,800.45.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_track_Glaxosmithkline_Pharmaceuticals_Share_Price_on_Univest\"><\/span><strong>Where can I track Glaxosmithkline Pharmaceuticals Share Price on Univest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> You can track Glaxosmithkline Pharmaceuticals Share Price on Univest for live price updates, fundamental ratios, shareholding pattern, company news and sector context. The platform brings GLAXO data together in one place for quick review.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Glaxosmithkline Pharmaceuticals Ltd. Share Price rises to Rs 2,890. marking a 3.2% rise today. Market cap stands at Rs 48,345.94 crore.<\/p>\n","protected":false},"author":29,"featured_media":257490,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-257494","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["257490"],"rank_math_title":["GLAXO Share Price today after 3.20% rise; valuation view"],"rank_math_description":["Glaxosmithkline Pharmaceuticals Share Price rose 3.20% to Rs 2,890 today. Read the price action, valuation, sector and peer context."],"rank_math_focus_keyword":["Glaxosmithkline Pharmaceuticals Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/Glaxosmithkline_Pharmaceuticals_Ltd_GLAXO_Glaxosmithkline_Pharmaceuticals_Share_Price_rises_320_today_to_Rs_2890_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/257494","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=257494"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/257494\/revisions"}],"predecessor-version":[{"id":257495,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/257494\/revisions\/257495"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/257490"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=257494"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=257494"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=257494"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}